Latest Breaking News On - Shalabh gupta - Page 4 : comparemela.com

Unicycive Therapeutics to Participate in Two Investor

LOS ALTOS, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage.

New yorkUnited statesShalabh guptaBoca ratonCompany or unicyciveUnicycive therapeutics incChief executive officerCapital marketsAnnual emerging growth equity conferenceDiscovery one on investorUnicycive therapeuticsNasdaq uncyUnicycive therapeuticsKidney disease

Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update

Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSara kenkare mitraShalabh guptaExchange commissionDevelopment rd expensesDrug administrationReason researchShire international licensingCompany or unicyciveAmerican society of nephrology kidney weekUnicycive therapeutics incReached alignmentData package requirementsClinical trial expectedInitiate before yearChief executive officer

Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC)

- Pivotal clinical trial expected to initiate before year end - LOS ALTOS, Calif., Oct. 23, 2023 Unicycive Therapeutics, Inc. , a clinical-stage biotechnology company developing therapies.

United statesShalabh guptaUnicycive therapeutics incDrug administrationReason researchCompany or unicyciveExchange commissionGlobenewswire incShire international licensingOxylanthanum carbonateNew drugChief executive officerEnd stage renal diseasePrivate securities litigation reform actRisk factorAnnual report

Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD

LOS ALTOS, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today

United statesUniversity of the pacificSan franciscoShalabh guptaSara kenkare mitraTherapeutic sciencesUnicycive therapeutics incUniversity of californiaAssociation for the advancement of scienceCompany or unicyciveExchange commissionCompany board of directorsDevelopment sciences in genentechHead of researchSciences recognitionAssociation of women

Unicycive Therapeutics Strengthens Board of Directors with

Appointment adds decades of drug development experience from a seasoned executive.

United statesSan franciscoUniversity of the pacificSara kenkare mitraShalabh guptaAssociation of womenLife sciencesUniversity of californiaCompany board of directorsUnicycive therapeutics incHead of researchCompany or unicyciveAssociation for the advancement of scienceSciences recognitionDevelopment sciences in genentechExchange commission